Literature DB >> 8034509

Successful control of poliomyelitis by a combined OPV/IPV polio vaccine program in the West Bank and Gaza, 1978-93.

T Tulchinsky1, Y Abed, R Handsher, N Toubassi, C Acker, J Melnick.   

Abstract

In the 1970s the incidence of poliomyelitis in Gaza and the West Bank was high, even among children immunized with as many as four doses of oral polio vaccine (OPV). This was thought to be due to interference in uptake from other enteroviruses in the environment. A combined program of OPV and inactivated polio vaccine (IPV) was instituted in these areas in 1978, and the incidence of polio declined dramatically. Wild poliovirus findings in sewage in 1990-91 coupled with two outbreaks of polio, one in Israel in 1988 and another in Jordan in 1992, were reminders that the area should still be considered endemic. The potential of fresh entry of wild poliovirus may occur via persons who may have personal protection but may still shed the virus due to inadequate enteric immunity. In addition, the combined program protects against vaccine-associated poliomyelitis. A similar modified combined OPV/IPV program has been adopted in Israel. The combination of OPV and IPV provides an important alternative strategy in the worldwide effort to eradicate poliomyelitis.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8034509

Source DB:  PubMed          Journal:  Isr J Med Sci        ISSN: 0021-2180


  4 in total

1.  Detection of poliovirus circulation by environmental surveillance in the absence of clinical cases in Israel and the Palestinian authority.

Authors:  Y Manor; R Handsher; T Halmut; M Neuman; A Bobrov; H Rudich; A Vonsover; L Shulman; O Kew; E Mendelson
Journal:  J Clin Microbiol       Date:  1999-06       Impact factor: 5.948

2.  Advanced environmental surveillance and molecular analyses indicate separate importations rather than endemic circulation of wild type 1 poliovirus in Gaza district in 2002.

Authors:  Y Manor; S Blomqvist; D Sofer; J Alfandari; T Halmut; B Abramovitz; E Mendelson; L M Shulman
Journal:  Appl Environ Microbiol       Date:  2007-07-27       Impact factor: 4.792

3.  Molecular and antigenic characterization of a highly evolved derivative of the type 2 oral poliovaccine strain isolated from sewage in Israel.

Authors:  L M Shulman; Y Manor; R Handsher; F Delpeyroux; M J McDonough; T Halmut; I Silberstein; J Alfandari; J Quay; T Fisher; J Robinov; O M Kew; R Crainic; E Mendelson
Journal:  J Clin Microbiol       Date:  2000-10       Impact factor: 5.948

4.  Resolution of the pathways of poliovirus type 1 transmission during an outbreak.

Authors:  L M Shulman; R Handsher; C F Yang; S J Yang; J Manor; A Vonsover; Z Grossman; M Pallansch; E Mendelson; O M Kew
Journal:  J Clin Microbiol       Date:  2000-03       Impact factor: 5.948

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.